<DOC>
	<DOCNO>NCT00375297</DOCNO>
	<brief_summary>This prospective double-blind , placebo-controlled ( DBPC ) study , assess efficacy sildenafil woman serotonin reuptake inhibitor antidepressant-associated sexual dysfunction ( SRI-AASD ) follow protocol previously establish efficacy men SRI-AASD .</brief_summary>
	<brief_title>Study Sildenafil Treatment SSRI-Antidepressant Sexual Dysfunction Women</brief_title>
	<detailed_description>This prospective double-blind , placebo-controlled ( DBPC ) study , assess efficacy sildenafil woman serotonin reuptake inhibitor antidepressant-associated sexual dysfunction ( SRI-AASD ) follow protocol previously establish efficacy men SRI-AASD . Women ( n=100 ) MDD-remission SRI-AASD randomize receive sildenafil ( 50-100mg ) placebo 8 week , follow 8-weeks open-label extension . Sexual function assess use Clinical Global Impression-Sexual Function ( CGI-SF ) , positive response define score &lt; 3 , UNM-SFI , ASEX , SFQ-FSD sexual function questionnaire . Depression monitor use HAM-D17 . Hypothalamic-pituitary-adrenal-gonadal hormone measure baseline DB-endpoint .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>S Subjects females , age 18 50 year . Subjects take SSRI , venlafaxine , nefazodone , tri/hetero cyclic antidepressant treatment depression least 8 week , currently stable dose antidepressant least 4 week , consistently experience arousal dysfunction [ inability attain maintain completion sexual activity adequate lubrication swell response sexual excitement ] orgasmic dysfunction [ delay orgasm/anorgasmia follow normal sexual excitement phase ] interfere sexual function least 4 week . Subjects must currently euthymic ( HAMD &lt; 10 ) without significant anxiety symptom ( HAMA &lt; 10 ) . Subjects must sexual dysfunction prior take antidepressant must clear temporal relationship sexual dysfunction antidepressant treatment . [ Note sexual dysfunction occur symptom depressive disorder AD treatment initiate consider preexist condition definition ] . Subjects must meet least one follow criterion : 1 . Inability orgasm ( anorgasmia ) , accord patient opinion . 2 . Clinically significant orgasm delay masturbation intercourse accord patient opinion : 1. represent meaningful delay compare subject ’ usual time achieve orgasm response sexual stimulation prior antidepressant medication 2. interferes subject ’ sexual function . 3 . Inability attain maintain completion sexual activity adequate lubrication swell response sexual excitement accord patient opinion interferes subject ’ sexual function compare prior antidepressant medication . Subjects must experience least one criterion item ( # 13 ) distress disability . Subjects must form regular sexual activity ( i.e. , masturbation , oral sex , intercourse ) least twice monthly prior antidepressant treatment willing continue effort sexual activity least weekly duration study . Subjects must good general physical health . Subjects must give informed consent participate study . Primary prior diagnosis sexual disorder ( side effect antidepressant drug symptom major depression ) . Vaginal , clitoral , sexual organ anatomical deformity . Posthysterectomy without oophorectomy without least six month postoperative normal sexual function precede depression antidepressant treatment . Any uncontrolled psychiatric disorder . Alcohol substance abuse dependence within past twelve month . Using likely use nitrate nitric oxide donor form ( oral , sublingual , buccal , transdermal , inhalational , aerosol ) . Hamilton Depression and/or Anxiety Scale score [ either ] &gt; 10 . Blood pressure outside 90/50 170/100 . Use investigational drug within prior 3 month study . Current use drug antidepressant induce sexual dysfunction . Hormone replacement therapy unless patient stable dose hormone therapy least 3 month prior antidepressant treatment sexual dysfunction hormone therapy regimen , change hormone replacement therapy study . Pregnancy , lactating , plan become pregnant study . Child bear potential subject unwilling and/or prepared and/or judge unreliable use acceptable verifiable form contraception study ( include IUD , double barrier hormonal method birth control ) . Any clinically significant abnormality screen physical examination safety laboratory test result . Subjects whose sexual partner suffer and/or receive treatment sexual dysfunction . eceiving psychosexual therapy sexual dysfunction willing discontinue treatment screen . Amenorrhea great 1 year . Subjects whose sexual dysfunction consider situational , i.e . limited certain type situation , stimulation , partner . Subjects attempt form regular sexual activity least twice monthly least weekly study visit interval duration entire study . Changes antidepressant agent dose prescribe antidepressant agent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>antidepressant</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>woman</keyword>
	<keyword>sildenafil</keyword>
	<keyword>PDE5 inhibitor</keyword>
	<keyword>serotonin reuptake inhibitor antidepressant</keyword>
</DOC>